White House pressures FDA on unproven Japanese drug for COVID— As Covid-19 hinders clinical trial operations, research staff are finding themselves out of work— Aspen Neuro adds $70M to test Parkinson's cell therapy — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page

Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.